NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab
{{output}}
Background: Early identification of cardiac dysfunction by non-invasive imaging in HER2-positive breast cancer patients treated with trastuzumab is challenging. In particular multigated acquisition (MUGA) scan, which is most wide... ...